These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18061370)

  • 1. Prevalence and predictors of comorbid diabetes among newly diagnosed Hispanic cancer patients in Connecticut.
    Polednak AP
    Cancer Detect Prev; 2007; 31(6):453-6. PubMed ID: 18061370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbid mental disorders in hospital records of Hispanic patients diagnosed with cancer in Connecticut.
    Polednak AP
    J Registry Manag; 2009; 36(4):111-6. PubMed ID: 20795552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obtaining data on comorbid diabetes among patients in a U.S. population-based tumor registry.
    Polednak AP; Phillips CE
    J Registry Manag; 2010; 37(2):57-64. PubMed ID: 21086823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study.
    Polednak AP
    Cancer Detect Prev; 2006; 30(5):466-72. PubMed ID: 17069990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying newly diagnosed Hispanic cancer patients who use a physician with a Spanish-language practice, for studies of quality of cancer treatment.
    Polednak AP
    Cancer Detect Prev; 2007; 31(3):185-90. PubMed ID: 17706369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collecting information on race, Hispanic ethnicity, and birthplace of cancer patients: policies and practices in Connecticut hospitals.
    Polednak AP
    Ethn Dis; 2005; 15(1):90-6. PubMed ID: 15720054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the prevalence of cancer in the United States.
    Polednak AP
    Cancer; 1997 Jul; 80(1):136-41. PubMed ID: 9210719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of cancer registry birthplace data for Hispanics living in the United States.
    Gomez SL; Glaser SL
    Cancer Causes Control; 2005 Aug; 16(6):713-23. PubMed ID: 16049810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-related emotional distress of Hispanic and non-Hispanic type 2 diabetes patients.
    Welch G; Schwartz CE; Santiago-Kelly P; Garb J; Shayne R; Bode R
    Ethn Dis; 2007; 17(3):541-7. PubMed ID: 17985511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival.
    Kuijpens JL; Janssen-Heijnen ML; Lemmens VE; Haak HR; Heijckmann AC; Coebergh JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):450-5. PubMed ID: 16584519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating complete prevalence of cancers diagnosed in childhood.
    Simonetti A; Gigli A; Capocaccia R; Mariotto A
    Stat Med; 2008 Mar; 27(7):990-1007. PubMed ID: 17724784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documentation of alcohol use in hospital records of newly diagnosed cancer patients: a population-based study.
    Polednak AP
    Am J Drug Alcohol Abuse; 2007; 33(3):403-9. PubMed ID: 17613967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasts in cancer prevalence in Connecticut, Iowa, and Utah.
    Micheli A; Yancik R; Krogh V; Verdecchia A; Sant M; Capocaccia R; Berrino F; Ries L
    Cancer; 2002 Jul; 95(2):430-9. PubMed ID: 12124844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Hispanic ethnicity in prevalence of diabetes mellitus in sleep apnea and relationship to sleep phase.
    Surani S; Aguillar R; Komari V; Surani A; Subramanian S
    Postgrad Med; 2009 Sep; 121(5):108-12. PubMed ID: 19820279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and depression care among medicaid beneficiaries.
    Sambamoorthi U; Olfson M; Wei W; Crystal S
    J Health Care Poor Underserved; 2006 Feb; 17(1):141-61. PubMed ID: 16520523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating breast cancer treatment charges in Connecticut.
    Polednak AP; Shevchenko IP; Flannery JT
    Conn Med; 1996 May; 60(5):263-7. PubMed ID: 8998905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
    Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
    J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of ethnicity in cancer data: which Hispanics are we misclassifying?
    Pinheiro PS; Sherman R; Fleming LE; Gomez-Marin O; Huang Y; Lee DJ; Penedo FJ
    J Registry Manag; 2009; 36(2):42-6. PubMed ID: 19694116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of risk factors for morbidity and mortality in the US Hispanic CF population.
    Watts KD; Seshadri R; Sullivan C; McColley SA
    Pediatr Pulmonol; 2009 Jun; 44(6):594-601. PubMed ID: 19437506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.